• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2014; 38(6) 639-650

Published on-line:

DOI:

Download in PDF:
Authentication required

Microbioma intestinale umano e metabolismo corporeo: implicazioni per obesità e diabete

AUTHORS

Sridevi Devaraj, Peera Hemarajata, James Versalovic
Department of Pathology and Immunology, Baylor College of Medicine and Department of Pathology, Texas Children's Hospital, Houston, USA
Traduzione a cura di Francesca Avemaria e Andrea Mosca

ABSTRACT

The human gut microbiome and body metabolism: implications for obesity and diabetes

Obesity, metabolic syndrome and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these three disorders. Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest and a myriad of host metabolic pathways. Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome and diabetes.

REFERENCES